Landfar Bio-medicine Co., Ltd (SHE:000504)
China
· Delayed Price · Currency is CNY 9.19
-0.30 (-3.16%)
Apr 30, 2026, 12:04 PM CST
Landfar Bio-medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 3,132 | 2,954 | 2,756 | 3,614 | 3,627 | 5,795 | Upgrade
|
| Market Cap Growth | -2.06% | 7.19% | -23.76% | -0.34% | -37.42% | 51.96% | Upgrade
|
| Enterprise Value | 3,218 | 2,941 | 2,522 | 3,679 | 3,774 | 6,136 | Upgrade
|
| Last Close Price | 9.49 | 8.95 | 8.35 | 11.60 | 11.64 | 18.60 | Upgrade
|
| PE Ratio | 105.44 | 102.46 | - | - | - | - | Upgrade
|
| PS Ratio | 7.53 | 7.10 | 20.50 | 26.42 | 18.10 | 37.00 | Upgrade
|
| PB Ratio | 8.76 | 8.26 | 9.77 | 11.86 | 45.23 | 52.53 | Upgrade
|
| P/TBV Ratio | 15.37 | 14.50 | 11.81 | 14.20 | 696.61 | 726.09 | Upgrade
|
| P/FCF Ratio | - | - | - | 119.05 | 24.27 | 77.13 | Upgrade
|
| P/OCF Ratio | - | - | 574.87 | 99.63 | 21.80 | 54.11 | Upgrade
|
| EV/Sales Ratio | 7.74 | 7.07 | 18.76 | 26.90 | 18.84 | 39.18 | Upgrade
|
| EV/EBITDA Ratio | 89.62 | 82.96 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 104.28 | 95.28 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -26.63 | - | - | 121.19 | 25.26 | 81.67 | Upgrade
|
| Debt / Equity Ratio | 0.96 | 0.96 | 0.09 | 0.67 | 2.95 | 2.83 | Upgrade
|
| Debt / EBITDA Ratio | 9.50 | 9.50 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 6.72 | 1.58 | 4.16 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.01 | -0.65 | -0.96 | 0.21 | 1.44 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.16 | -0.16 | 14.36 | 8.70 | -1.65 | -8.62 | Upgrade
|
| Net Debt / FCF Ratio | 0.05 | 0.05 | 13.65 | -9.61 | 0.11 | 2.11 | Upgrade
|
| Asset Turnover | 0.52 | 0.52 | 0.20 | 0.21 | 0.33 | 0.26 | Upgrade
|
| Inventory Turnover | 12.30 | 12.30 | 2.00 | 5.92 | 9.64 | 3.62 | Upgrade
|
| Quick Ratio | 1.26 | 1.26 | 1.18 | 1.41 | 0.89 | 0.68 | Upgrade
|
| Current Ratio | 1.36 | 1.36 | 1.32 | 1.45 | 0.91 | 0.98 | Upgrade
|
| Return on Equity (ROE) | 5.65% | 5.65% | -8.16% | -24.31% | -30.93% | -27.04% | Upgrade
|
| Return on Assets (ROA) | 2.41% | 2.41% | -1.39% | -3.45% | -1.33% | -2.26% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.72% | 12.55% | -27.62% | -66.71% | -7.06% | -7.22% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 6.90% | -5.10% | -11.50% | -13.10% | -16.80% | Upgrade
|
| Earnings Yield | 0.92% | 0.98% | -0.72% | -0.78% | -0.34% | -0.33% | Upgrade
|
| FCF Yield | -3.86% | -4.09% | -0.49% | 0.84% | 4.12% | 1.30% | Upgrade
|
| Payout Ratio | 8.20% | 8.20% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 3.16% | 3.16% | -5.67% | -0.51% | 2.30% | -17.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.